SCHEMBL6497592

SCHEMBL6497592

CN(CNC=O)c1ccccc1

nearest known ligand 0.45

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ADH1B P00325 1/20 0.45
ADH1C P00326 1/20 0.45
ADH1A P07327 1/20 0.45
ADH7 P40394 1/20 0.45
CA12 O43570 1/20 0.43
CA2 P00918 1/20 0.43
CA9 Q16790 1/20 0.43
KMT2A Q03164 3/20 0.39
MEN1 O00255 2/20 0.39
HTT P42858 1/20 0.39
CRHBP P24387 1/20 0.38
CRHR2 Q13324 1/20 0.38
ALDH1A1 P00352 2/20 0.35
TAAR1 Q96RJ0 3/20 0.35
GLA P06280 1/20 0.34
TSHR P16473 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20057564 0.81 ADH1B (0.42) ADH1BADH1CADH1AADH7CA12
SCHEMBL6503492 0.79 ADH1B (0.48) ADH1BADH1CADH1AADH7KMT2A
SCHEMBL12643373 0.78 BCHE (0.46) ADH1BADH1CADH1AADH7CA12
SCHEMBL10818547 0.74 ALDH1A1 (0.48) ADH1BADH1CADH1AADH7KMT2A
SCHEMBL22137457 0.73 CA12 (0.44) CA12CA2CA9KMT2AMEN1
SCHEMBL3928290 0.72 CA12 (0.47) CA12CA2CA9KMT2AMEN1
SCHEMBL8271347 0.72 MTNR1A (0.58) CA12CA2CA9HTT
SCHEMBL668864 0.71 ALDH1A1 (0.43) CA12CA2CA9KMT2AMEN1
SCHEMBL5638853 0.71 PPIB (0.49) KMT2AMEN1HTTALDH1A1
SCHEMBL22482415 0.69 MTNR1A (0.39) CA12CA2CA9KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005016883-A2 ACRYLAMIDE DERIVATIVES AS VLA-1 INTEGRIN ANTAGONISTS AND USES THEREOF ICOS CORPORATION (US) 2005-02-24 WO claimed
WO-2005016883-A2 ACRYLAMIDE DERIVATIVES AS VLA-1 INTEGRIN ANTAGONISTS AND USES THEREOF ICOS CORPORATION (US) 2005-02-24 WO disclosed